12.07.2023
AC-065A310 SALTO
A randomized, multicenter, double-blind, placebo controlled, parallel-group, event-driven, group-sequential study with open-label extension period to assess the efficacy and safety of selexipag as add-on to standard of care in children with pulmonary arterial hypertension <polmonare
Show more12.07.2023
CLCZ696B2319E1 PANORAMA extension
A multicenter study to evaluate long-term safety and tolerability of open label sacubitril/valsartan in pediatric patients with heart failure due to systemic left ventricle systolic dysfunction who have completed study CLCZ696B2319
Show more12.07.2023
GE-262-001
An Open-label, Single-dose, Safety and Pharmacokinetic Study of Regadenoson in Paediatric Patients
Show more12.07.2023
SAXOPHONE CV185362
A Prospective, Randomized, Open Label, Multi-center Study of the Safety and Pharmacokinetics of Apixaban versus Vitamin K Antagonist or LMWH in Pediatric Subjects with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention
Show more